| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 22/06/2023 | 23:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CVLB | Conversion Labs Inc |
| 22/06/2023 | 23:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CVLB | Conversion Labs Inc |
| 22/06/2023 | 23:00 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CVLB | Conversion Labs Inc |
| 31/05/2023 | 13:16 | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:CVLB | Conversion Labs Inc |
| 28/04/2023 | 15:12 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:CVLB | Conversion Labs Inc |
| 22/03/2023 | 22:08 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CVLB | Conversion Labs Inc |
| 06/02/2023 | 22:41 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:CVLB | Conversion Labs Inc |
| 10/11/2022 | 23:06 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CVLB | Conversion Labs Inc |
| 17/08/2022 | 15:15 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:CVLB | Conversion Labs Inc |
| 08/07/2022 | 12:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CVLB | Conversion Labs Inc |
| 01/07/2022 | 22:19 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CVLB | Conversion Labs Inc |
| 30/09/2021 | 12:05 | Edgar (US Regulatory) | Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) | NASDAQ:CVLB | Conversion Labs Inc |
| 28/09/2021 | 22:13 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:CVLB | Conversion Labs Inc |
| 23/07/2021 | 23:01 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:CVLB | Conversion Labs Inc |
| 17/06/2021 | 22:56 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3/a) | NASDAQ:CVLB | Conversion Labs Inc |
| 21/05/2021 | 12:09 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:CVLB | Conversion Labs Inc |
| 29/04/2021 | 23:56 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/a) | NASDAQ:CVLB | Conversion Labs Inc |
| 28/04/2021 | 23:32 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:CVLB | Conversion Labs Inc |
| 28/04/2021 | 23:31 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:CVLB | Conversion Labs Inc |
| 23/04/2021 | 17:35 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:CVLB | Conversion Labs Inc |
| 15/04/2021 | 13:43 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CVLB | Conversion Labs Inc |
| 22/02/2021 | 09:30 | GlobeNewswire Inc. | Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD | NASDAQ:CVLB | Conversion Labs Inc |
| 17/02/2021 | 15:25 | GlobeNewswire Inc. | Conversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Februar... | NASDAQ:CVLB | Conversion Labs Inc |
| 12/02/2021 | 14:30 | GlobeNewswire Inc. | Conversion Labs to Become Life MD™ with Launch of New Concierge Telehealth Services | NASDAQ:CVLB | Conversion Labs Inc |
| 05/02/2021 | 14:31 | GlobeNewswire Inc. | Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer | NASDAQ:CVLB | Conversion Labs Inc |
| 28/01/2021 | 23:31 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:CVLB | Conversion Labs Inc |
| 28/01/2021 | 16:30 | GlobeNewswire Inc. | Conversion Labs Increases Stake in Fast-Growing SaaS Subsidiary | NASDAQ:CVLB | Conversion Labs Inc |
| 19/01/2021 | 14:31 | GlobeNewswire Inc. | Conversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million | NASDAQ:CVLB | Conversion Labs Inc |
| 11/01/2021 | 14:31 | GlobeNewswire Inc. | Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer | NASDAQ:CVLB | Conversion Labs Inc |
| 06/01/2021 | 22:01 | GlobeNewswire Inc. | Conversion Labs to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 | NASDAQ:CVLB | Conversion Labs Inc |